Zobrazeno 1 - 10
of 583
pro vyhledávání: '"Domenica Lorusso"'
Autor:
Floriana Camarda, Mariachiara Paderno, Maria Chiara Cannizzaro, Camilla Nero, Ilaria Sabatucci, Giovanni Fucà, Lucia Musacchio, Vanda Salutari, Giovanni Scambia, Domenica Lorusso
Publikováno v:
Therapeutic Advances in Medical Oncology, Vol 16 (2024)
Cervical cancer (CC) is still characterized by a poor prognosis despite the progress made in its treatment in recent years. Although immunotherapy has improved outcomes for advanced/recurrent disease, there is a significant gap in addressing patients
Externí odkaz:
https://doaj.org/article/a32e045a7b8b48adb04dd3a85af00de2
Autor:
Nicoletta Colombo, Domenica Lorusso, Bradley J. Monk, Brian Slomovitz, Kosei Hasegawa, Angélica Nogueira-Rodrigues, Melissa Zale, Chinyere E. Okpara, Gianmaria Barresi, Jodi McKenzie, Vicky Makker
Publikováno v:
Клинический разбор в общей медицине, Vol 4, Iss 12, Pp 62-75 (2023)
Background. Lenvatinib plus pembrolizumab significantly improved efficacy compared with chemotherapy in patients with advanced endometrial cancer (aEC) regardless of microsatellite instability status or histologic subtype, who had disease progression
Externí odkaz:
https://doaj.org/article/710c4a0b98014278bf805931cfc7c196
Autor:
Matteo Valerio, Alessandro Inno, Alberto Zambelli, Laura Cortesi, Domenica Lorusso, Valeria Viassolo, Matteo Verzè, Fabrizio Nicolis, Stefania Gori
Publikováno v:
Cancers, Vol 16, Iss 16, p 2845 (2024)
(1) Background: The identification of tumor subtypes is fundamental in precision medicine for accurate diagnoses and personalized therapies. Cancer development is often driven by the accumulation of somatic mutations that can cause alterations in tis
Externí odkaz:
https://doaj.org/article/858e24ce7aa147cf93a29b5ed4be0b1f
Autor:
Martina Arcieri, Veronica Tius, Claudia Andreetta, Stefano Restaino, Anna Biasioli, Elena Poletto, Giuseppe Damante, Alfredo Ercoli, Lorenza Driul, Anna Fagotti, Domenica Lorusso, Giovanni Scambia, Giuseppe Vizzielli
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
About 50% of High Grade Serous Ovarian Cancer exhibit a high degree of genomic instability due to mutation of genes involved in Homologous Recombination (HRD) and such defect accounts for synthetic lethality mechanism of PARP inhibitors (PARP-i). Sev
Externí odkaz:
https://doaj.org/article/3d1bed078930434ca0103b78ab067442
Autor:
Michele Mongelli, Domenica Lorusso, Vanna Zanagnolo, Sandro Pignata, Nicoletta Colombo, Gennaro Cormio
Publikováno v:
Diagnostics, Vol 14, Iss 11, p 1159 (2024)
Cancer-associated thrombosis is the second leading cause of death in cancer patients, and its incidence has been increasing in recent years. This survey was aimed at gathering information regarding the management of thromboembolic prophylaxis within
Externí odkaz:
https://doaj.org/article/1a4bddfec65542fcae0c009a7a2ebf03
Autor:
Anna Falanga, Domenica Lorusso, Nicoletta Colombo, Gennaro Cormio, Benilde Cosmi, Giuseppa Scandurra, Vanna Zanagnolo, Marco Marietta
Publikováno v:
Cancers, Vol 16, Iss 9, p 1769 (2024)
The prevention and appropriate management of venous thromboembolism in cancer patients is of paramount importance. However, the literature data report an underestimation of this major problem in patients with gynecological cancers, with an inconsiste
Externí odkaz:
https://doaj.org/article/d45a43ea4e07403da277267b3d41f8c6
Autor:
Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Vera Loizzi, Claudio Zamagni, Antonella Savarese, Massimo Di Maio, Graziana Ronzino, Carmela Pisano, Sandro Pignata, Giorgio Valabrega
Publikováno v:
Frontiers in Oncology, Vol 13 (2024)
Externí odkaz:
https://doaj.org/article/dcf619c78545464a823c5d3ef4cc8cc3
Autor:
Luca Forlani, Loris De Cecco, Vittorio Simeon, Biagio Paolini, Marina Bagnoli, Sabrina Chiara Cecere, Anna Spina, Eleonora Citeroni, Eliana Bignotti, Domenica Lorusso, Laura Arenare, Daniela Russo, Carmine De Angelis, Laura Ardighieri, Giosuè Scognamiglio, Michele Del Sesto, Germana Tognon, Daniela Califano, Clorinda Schettino, Paolo Chiodini, Francesco Perrone, Delia Mezzanzanica, Sandro Pignata, Antonella Tomassetti
Publikováno v:
Journal of Experimental & Clinical Cancer Research, Vol 42, Iss 1, Pp 1-17 (2023)
Abstract Background Validated prognostic biomarkers for anti-angiogenic therapy using the anti-VEGF antibody Bevacizumab in ovarian cancer (OC) patients are still an unmet clinical need. The EGFR can contribute to cancer-associated biological mechani
Externí odkaz:
https://doaj.org/article/218fe5829cc64926a70c90f947c39308
Autor:
Francesca Arezzo, Gaia Giannone, Daniele Castaldo, Giulia Scotto, Valentina Tuninetti, Margherita Turinetto, Michele Bartoletti, Serafina Mammoliti, Grazia Artioli, Giorgia Mangili, Vanda Salutari, Domenica Lorusso, Gennaro Cormio, Vera Loizzi, Claudio Zamagni, Antonella Savarese, Massimo Di Maio, Graziana Ronzino, Carmela Pisano, Sandro Pignata, Giorgio Valabrega
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
IntroductionEndometrial cancer (EC) represents 3.4% of all newly diagnosed cancer cases and is responsible for 2.1% of all cancer-related deaths. Approximately 10%–15% of women with EC are diagnosed with advanced-stage disease, resulting in a repor
Externí odkaz:
https://doaj.org/article/f5bb38ac79f64befb91e18a43fc5f3ed
Autor:
Domenica Lorusso, Romano Danesi, Laura Deborah Locati, Gianluca Masi, Ugo De Giorgi, Angiolo Gadducci, Sandro Pignata, Roberto Sabbatini, Antonella Savarese, Giorgio Valabrega, Claudio Zamagni, Nicoletta Colombo
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Externí odkaz:
https://doaj.org/article/01160f11902f41b39a39a31497957622